8th November 2018, The Strand Palace, London



2018 Testimonials

"I was impressed by the quality of all the speakers"

- Anna Halstead, Research Project Manager, Newcastle In Vitro Diaganostics Cooperative

"Nice and interesting meeting. Very well organized. People approachable and open debates"

- Juan Diaz, Application Scientist, Agilent Technologies UK 

"Educative and well organised“

- Mojisola Ajeneye, Devices Team Manager, MHRA

"Overall, I enjoyed the conference. It was also a great opportunity to meet people and network"

- Fiona Robbins, Account Manager, NAMSA

2018 Conference Slideshow

Our 2018 conference has passed, but you can view slide show presentations from the conference by registering below.

Pathology consolidation and innovation to drive efficient patient care

To read a Blog from David Wells, Head of Pathology Services Consolidation at NHS Improvement click HERE




lumiraDx was founded in 2014 by a group of entrepreneurs with a successful track record in building and scaling diagnostics and health IT businesses. These included Medisense, Inverness Medical and Alere.

Visit the lumiraDx website

CIGA Healthcare, specialists in In-Vitro Point of Care Diagnostics, aids healthcare in producing financial savings and improving patient pathways and experience through the provision of innovative rapid, easy to use and accurate point of care diagnostic tests and equipment.

We look forward to meeting you at the UK Diagnostics Summit, in the meantime do visit our web site at www.sursignprofessional.com
Accelerate Diagnostics UK Ltd

Accelerate Diagnostics UK Ltd is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections. The Accelerate PhenoTM system is the first to provide rapid identification and MIC- based susceptibility results, direct from sample, in hours instead of days - identification in about 90 minutes, antibiotic susceptibility 5 hours later-.

These fast results will enable clinicians to make targeted, lifesaving therapy decisions 1- 2 days earlier. Ultimately, they will be able to optimize antimicrobial therapy sooner.

For more information click HERE

The Novarum™ Reader is the smart new way to read diagnostic tests and share the data with healthcare providers all over the world – or just round the corner.

By turning almost any smartphone into a mobile test reader, Novarum’s custom software means you can test in any location and send qualitative or quantitative results straight to another phone or device. Clearly, quickly, and accurately. You can then share results between users, in the cloud, using our specially designed web interface or through your existing data management platforms.
Hologic logo
Life Arc

Pioneering new ways to turn great science into greater patient impact.

For more information click HERE
Oxford BioSystems

Based in Milton Park, Oxfordshire, Oxford Biosystems was established in 2001 with the aim of sourcing reliable, quality in-vitro diagnostic products and research tools for clinical, industrial and research laboratories.

In 2009 the joining of Cadama Medical Ltd (founded in Birmingham, UK in 2002) with Oxford Biosystems brought together expertise in a wide variety of technologies including ELISA, IRMA, RIA, Real time PCR, EliSpot and Image analysis.

Oxford Biosystems are full members of BIVDA and company members of IBMS and are proud to hold ISO 9001:2015 certification. The company has pledged to be an Antibiotic Guardian in the global challenge of antimicrobial resistance.

At the beginning of 2015 the majority shareholding of Oxford Biosystems was purchased by BioVendor – Laboratorni Medicina a.s, with whom we have had a successful relationship as their UK distributor for many years.

We look forward to an exciting future incorporating new suppliers and technologies with the support of BioVendor.

For more information click HERE

We’re dedicated to fulfilling the promise of human potential, in all places, in all aspects and stages of life. We believe that health is the key to that promise. Because at our healthiest, we’re capable of achieving anything. And that’s why our pursuit of helping people achieve their best health at every life stage will never end. This is how we put that belief into practice each and every day.

We are here for the people we serve in their pursuit of healthy lives. This has been the way of Abbott for more than a century—passionately and thoughtfully translating science into lasting contributions to health.

Our products encircle life, from newborns to ageing adults, from nutrition and diagnostics through medical care and pharmaceutical therapy.

Caring is central to the work we do and defines our responsibility to those we serve.

For more information click HERE

Hologic is the developer, manufacturer, and supplier of the world’s most operationally efficient solutions for molecular diagnostic testing and cervical screening. Our products include the Panther and Panther Fusion systems running the class leading Aptima assays for STI screening, viral load monitoring and respiratory sample testing. Hologic’s complete cervical screening solution includes the ThinPrep Liquid Based Cytology system and the novel Aptima HPV E6/E7 mRNA test running on the Panther and Tomcat systems.

For more information visit www.hologic.com.
orion diagnostica logo GenMark Dx logo prospect logo
Orion Diagnostica

Orion Diagnostica is a European IVD company with over 40 years’ experience focusing on Point-of-Care (POC) diagnostics. We develop, manufacture and market fast, reliable and easy to use diagnostic tools for healthcare professionals, in various settings in over 60 countries. Our test systems are designed to assist healthcare professionals in making evidence based diagnoses, appropriate treatment decisions and follow up on treatment response.

Our flagship, the portable multianalyte QuikRead go system, combines high quality and fast results with easiness of use and full connectivity options. The expanding QuikRead go® product portfolio consists of the following laboratory quality POC tests: various quantitative CRP tests, separate and in combination with Hb (CRP+Hb) to fit all your CRP testing needs, Strep A for detection of Streptococcus pyogenes in throat samples and iFOBT for detection and quantification of human haemoglobin in faeces.

QuikRead go diagnostic tests provide you a reliable solution in tackling antimicrobial resistance (AMR). For more information about our fight against AMR you can find at www.tackleamr.com.
GenMark Diagnostics

GenMark’s ePlex true sample-to-answer system symbolizes the evolution of eSensor technology combined with digital microfluidics. ePlex offers unique solutions to address the most significant challenges facing clinical laboratories, while supporting hospital systems to deliver patient-centered, value-based care. ePlex streamlines the diagnostic workflow from physician order entry to the final test report, and is the only true sample-to-answer solution designed to improve patient care, reduce costs, and increase lab efficiency.

Prospect Diagnostics Limited

Prospect Diagnostics Limited is a leading company in the supply, logistics and support of point of care medical diagnostic devices and consumables to the UK Healthcare sector. We value our relationships with our suppliers, and pride ourselves on the quality of our customer service through:
  • Partnership with leading diagnostics manufacturers and healthcare supplies worldwide
  • Always seeking to introduce innovative and effective diagnostic solutions
  • We supply and support over 5,000 ‘point of care’ practitioners throughout the UK
  • We have a greater than 98.5% success record over 20 years in despatching goods on same day as receipt of order for next day delivery
  • We are a committed and accredited ‘Investor in People’ business




8 NOV 2018

*Programme subject to change

08:45 - Delegate Registration, Expo & Surgeries

Exhibition takes place in Foyer and Exeter 2

09:30 - Conference Chair Introduction

Speaker: Doris-Ann Williams MBE, Chief Executive, BIVDA

09:40 - Keynote Address - UK AMR Diagnostics Collaborative

Speaker: Fiona Carragher, Deputy Chief Scientific Officer, NHS England

9.50 - How diagnostics can drive efficiency within the NHS

Speaker: Professor Adrian Newland CBE, Professor of Haematology, Barts and the London School of Medicine and Dentistry

10.05 – Using Pathology networks to drive efficient patient care

Speaker: David Wells, Head of Pathology Services Consolidation, NHS Improvements

10:20 - A partnered development of a circulating tumour ESR1 Mutation Test for the detection of metastatic breast cancer mutations indicative of resistance to endocrine hormone therapy

Speaker: Ciaran Fulton, Head of Diagnostics, Centre for Diagnostics Development (CDD), LifeArc

10:35 - Smartphone-enabled point of care testing - transforming the way we approach diagnosis and treatment

Speaker: Dr Neil Polwart, Novarum Founder, BBI Group Head of Mobile

As mobile technology has an ever increasing impact on our lives the permeation of mobile technology into diagnosis and treatment of disease is almost inevitable.Whilst there are many ways to envisage point of care tests integrating with mobile phones, we will describe our patent protected approach to detecting, analysing and interpreting low cost simple to use diagnostic devices for use outside traditional clinical laboratories.

In addition to describing case studies for projects covering a range of applications including infectious disease and monitoring chronic conditions, we will outline a vision for how smartphone connected point of care testing can be used to introduce improved antimicrobial stewardship.

10:50 - Panel Debate- How do we create a diagnostic pathway for the UK

Chair: Daniel Berman, Longitude Prize, Challenge Prize Centre, Nesta

Panelist: Doris-Ann Williams, Chief Executive, BIVDA

Panelist: Fiona Carragher, Deputy Chief Scientific Officer, NHS England

Panelist: Professor Adrian Newland CBE, Professor of Haematology, Barts and the London School of Medicine and Dentistry

Panelist: David Wells, Head of Pathology Services Consolidation, NHS Improvements

11:30 - Refreshments, Expo & Surgeries

11:50 - Diagnostics in action- Workshop Breakout session 1-

Delegates choose 1 stream from each workshop session

Essex Suite- Stream 1 - Improvement in the quality and reproducibility of diagnostic assays

This presentation will address the application of reference materials measuring quality linked to a primary physical reference “the International Standard”, wherever possible, can provide assurance of the quality of the data and, in turn, support improved clinical management of patients.

Speaker: Clare Morris, Senior Scientist, NIBSC

Exeter 1-Stream 2 - Improving clinician confidence and decision making in the management of patients over 65 presenting with acute frailty syndromes-

As sponsored by Abbott

This presentation will address a project which with the addition of a diagnostic tool facilitated improved decision making, earlier identification of illness and better patient management.

Speaker: Melinda McPherson, Trainee Advanced Clinical Practitioner, South central Ambulance Service

12.30- Diagnostics in action- Workshop Breakout session 2

Exeter 1-Stream 3- BiomArker-guided Duration of Antibiotic treatment in hospitalised PaTients with suspected Sepsis: the ADAPT-Sepsis Trial

This presentation will explore a recent UK-wide multi-centre randomised controlled trial to determine whether a treatment protocol based on monitoring CRP or PCT safely allow a reduction in duration of antibiotic therapy in hospitalised adult patients with suspected sepsis

Speaker: Professor Paul Dark, Chair of Critical Care Medicine, Manchester University NHS Foundation Trust and Northern NHS Care Alliance

Essex suite-Stream 4 -Real-world evaluation and implementation of a diagnostic test for pre-eclampsia

Pre-eclampsia (PE) is a multisystem hypertensive disorder that affects 3-5% of all pregnancies. The disease is a serious cause of maternal and foetal morbidity in the UK and clinical teams therefore have a high degree of suspicion for the disease and a low threshold for admitting pregnant women with suspected PE

Oxford AHSN has been leading a project with Roche Diagnostics and clinicians in the Oxford AHSN region to evaluate and implement the Elecsys® test as part of a new clinical pathway to reduce patient risk in maternity units. This workshop highlights the challenges and benefits of introducing a new clinical pathway and the importance of conducting a robust real world evaluation to facilitate implementation.

Speakers: Julie Hart & Guy Checketts, Oxford AHSN

13.10 - Lunch, Expo,Poster Session & Surgeries

Overcoming the challenges and progressing the Diagnostics landscape

14:00 - In-Vitro diagnostic regulations, challenges and opportunities in a post-Brexit UK

Speaker: Alison Dennis, Partner, Fieldfisher

14:15 - CASE STUDY in diagnostic test research: the i-sense EPSRC IRC in Early Warning Sensing Systems for Infectious Diseases

Speaker: Rachel McKendry, Professor, Biomedical Nanotechnology, London Centre for Nanotechnology, UK

14:35 -CASE STUDY: CRP in Community Pharmacies

A recent study conducted in UK and estimated an 80% reduction in antibiotic Rx and also significantly reduced the attendance at GPs surgery. These two factors make community pharmacy a cost effective site for POC CRP testing. As a result, the intervention has been included in NHS England grant to extend the service to more pharmacies already engaged in providing access to medication for the treatment of ear, nose, throat (ENT) conditions and for bacterial conjunctivitis which is due to start this coming flu season. In addition it is planned to educate all members of the community-GP surgeries, schools, community groups etc in the town where the first trial was conducted to create a fully integrated POC CRP testing service in which all of the community are engaged.

Speaker: Mike Wakeman, Pharmacist & Healthcare Consultant

14:55 -CASE STUDY: Making the business case for Diagnostics within your organisation

As sponsored by Abbott

Oldham has issues with higher levels of antibiotic prescribing than most other Greater Manchester CCGs. Oldham has the 2nd highest weighted prescribing of antibacterial. QIPP indicator (Quality, Innovation, Productivity and Prevention) showed 22 Oldham practices in the bottom national quartile. Oldham Antimicrobial policy developed in 2013 in collaboration with North East sector to provide guidance to GPs about appropriate antibiotic prescribing on commonly presented infections. This failed to reduce the prescribing. In this presentation Anita Sharma will discuss how she gained funding support to tackle these high levels and her findings.

Speaker: Dr Anita Sharma,GPwSI Gynaecology, Clinical Lead Oldham GP Federation

15:15 - Closing Keynote- How Diagnostics make economic sense for the NHS

Lord O'Neill will present on the economic benefits brought to the UK Economy by utilising Diagnostics within our health service. Jim will address how Diagnostics is the single most important intervention in tackling Antimicrobial Resistance

Speaker: Lord Jim O'Neill of Gatley

15:35 - Chair closing remarks

15:40 - Conference Close

Check back soon for the 2018 conference. You can view slides from our 2017 conference by clicking the button below. 




David Wells

Newland CBE

Neil Polwart photo


Ciaran Fulton photo

Lord Jim

September 2018 saw David recognised as being one of the 100 best, brightest and most powerful advocates for pathology in the global community by the Pathologist magazine. David is leading the NHS Improvement Pathology consolidation programme, seeking to deliver efficient, high quality pathology services across England. One year on Pathology services are embracing this considerable change at a pace not previously seen.

David has a diverse experience of providing and leading pathology services to primary, secondary and tertiary care across all pathology disciplines. Trained at Addenbrookes Hospital qualifying in December 2000, followed by a number of roles including Great Ormond Street Hospital as the Lead Healthcare Scientist for GOSH, covering the entire Healthcare Science workforce, the first person to hold this post and as Director of Operations at Viapath covering Kings College Hospital and Guy’s and St Thomas’ Hospitals one of the UK’s largest networked pathology services.

David is an elected IBMS council member for the London Region. David has also represented the IBMS on NICE diagnostic advisory panels, and various national forums including an observer on the Royal College of Pathologist Council and in the Parliamentary and Science committee

Professor Adrian Newland CBE, Professor of Haematology at Barts and the London NHS Trust

Adrian Newland is a Professor of Haematology at Barts and the London NHS Trust, where he developed the leukaemia and bone marrow transplant unit in the early 1980s. He now has a particular interest in immunohaematology and is studying the molecular basis of autoimmune disease, in particular thrombocytopenia, and piloting the clinical use of novel treatments. He is also Centre Lead for Haematology in the Medical School, Director of Pathology for the Trust and Clinical Director of the North East Thames Cancer Network.
Ciaran Fulton is Head of Diagnostics at LifeArc's Centre for Diagnostic Development (CDD) in Edinburgh. With over 15 years' experience in the molecular diagnostic IVD sector he gained his PhD in Molecular Biology at The Queen's University of Belfast and subsequently completed a number of post-doctoral positions at both Queen's and University College Cork where he was an associate lecturer.

Prior to joining LifeArc, Ciaran spent 10 years at Almac Diagnostics in various roles including managing both the company's Service and CLIA laboratories. He has also worked at the Molecular Biology Group at Randox Laboratories as a research scientist developing markers for use in breast cancer diagnostics.

As Head of Diagnostics, Ciaran has overall responsibility for the delivery of diagnostic development projects including all aspects of product development through to clinical evaluation as well as responsibility for the bioinformatics, quality and project management functions within LifeArc.
Lord Jim O'Neill

Lord O’Neill will become the Chair of Chatham House In July. Jim is the Vice Chair of the Northern Powerhouse Partnership. Lord O’Neill is also Chairing the International Advisory Board for the Productivity Insights Network+ Programme, co-ordinated by Sheffield University. He is a member of the Shelter Social Housing Commission. Since leaving from Government in September 2015, having been Commercial Secretary to the Treasury, Jim moved to the Crossbenches of the House of Lords.

Jim led an independent Review into Antimicrobial Resistance (AMR) for David Cameron from late 2014 to September 2016, and remains focused on this challenge. He has recently published a book, “ Superbugs, An Arms Race Against Bacteria” with two of his Review team colleagues, and was also awarded a Fellowship from the Society for Applied Microbiology for his AMR work.

In 2013/ 2014, Jim chaired the Cities Growth Commission in the UK, which formed the impetus for the government’s policy on devolution as well as the concept of the Northern Powerhouse.

Jim earned BA and MA degrees in economics from Sheffield University in 1978 and a PhD from the University of Surrey in 1982. He has honorary degrees from the Institute of Education, University of London, for his educational philanthropy, from City University for his services to banking and finance, and from Sheffield University in recognition of his contribution to international economics. Jim is an Honorary Fellow of the Faculty of Public Health , a Fellow at the Society for Applied Microbiology,and a Fellow of the Academy of Social Sciences.


Fiona Carragher photo


Clare Morris photo


Melinda McPherson photo

Professor Paul

Professor Paul Dark photo
Fiona Carragher is the Deputy Chief Scientific Officer for England, supporting the head of profession for the 50,000 healthcare science workforce in the NHS and associated bodies – embracing more than 50 separate scientific specialisms. A Consultant Clinical Biochemist by background, Fiona has a broad portfolio of policy responsibilities, providing professional leadership and expert clinical advice across the health and care system as well as working with senior clinical leaders within both the NHS England and the wider NHS.

Fiona has a strong background in both public health and treatment & care, having led and worked in multi-professional teams for two decades at Guy’s & St Thomas’ Hospital, the Royal Hospital for Sick Children, Edinburgh and Kings College Hospital, London – with a focus on providing high quality, innovative laboratory services. More recently she led a number of specialised laboratories for the diagnosis and monitoring of inherited metabolic disease and was Director of Newborn Screening for the South East Thames Region.

She has led a number of broader healthcare science projects including technology adoption and leadership development, and created a proactive scientific and diagnostics network across London that supports quality improvement and effective commissioning.
Clare joined NIBSC in 1998 as a scientist responsible for screening plasma pools for the presence of HIV, following a 2-year graduate post at Hammersmith Hospital working on an HIV drug response clinical trial.

She now has over 16 years of experience in the field of development of international standards and working reagents.

Her main interests are the development of international standards for use in clinical diagnosis and the improvement of current standards to adapt to new technologies.
Melinda (Dolly) is a ‘Specialist Paramedic - urgent care’ in the South Central Ambulance Service and a Trainee Advanced Clinical Practitioner at Royal Berkshire Hospital. She is a degree paramedic who is currently working towards completing her MSc in Advanced Practice. She has experience in the NHS across a number of environments including the ambulance service, minor injuries, the emergency department and within GP practices. She has an interest in reading and writing academic literature with previous publications in the Journal of Paramedic Practice and now Standby CPD.

It is her aim to add to the evidence base that currently inspires paramedic practice whilst learning from it herself. Dolly has been fortunate enough to benefit from senior clinical mentors throughout her training and career such as lifetime Paramedics, Emergency Care Practitioners (ECP), Advanced Care Practitioners (ACP) and General Practitioners (GP). She hopes that the knowledge that she has benefited from can be transferred into her writing to help others within the Paramedic profession.
Professor Dark studied undergraduate physics and then medicine. Graduating from The Manchester Medical School in 1989, he went on to study clinical academic surgery, emergency medicine and critical care at the Universities of Glasgow and Manchester in the UK, and at the Catholic University of Leuven, Belgium. He was a MRC Clinical Training Fellow, completing a PhD supervised by Professor Rod Little at the MRC Trauma Unit in 2002, where he developed non-invasive technologies to transduce and study dynamic cardio-respiratory responses to tissue injury and haemorrhage.

Appointed by the University of Manchester in 2003, he developed his clinical academic practice in Critical Care Medicine as Honorary NHS Consultant at Salford Royal NHS Foundation Trust. He provides leadership for a programme of work funded by the National Institute of Health Research (NIHR) developing and assessing the diagnostic utility of emerging molecular technologies in the setting of sterile tissue injury and severe infection - focused on matrices in blood and breath. Funded by Innovate UK, he has also led a programme of work developing novel technologies aimed at rapid point-of-care infection/sepsis diagnosis and he has advised NICE at a number of diagnostic technology appraisals.

Professor Dark is Academic Director for Greater Manchester’s Major Trauma Centre Collaborative and is NIHR National Research Lead for Critical Care based at King’s College London.

Williams MBE


Dr Neil

Neil Polwart photo


Alison Dennis


Mike Wakeman
Doris-Ann Williams has been Chief Executive of BIVDA since October 2001. She has more than 35 years’ experience in the IVD sector. She has held a variety of roles, initially in R&D at Amersham International/Amerlite Diagnostics Ltd and subsequently in commercial roles internationally for Becton Dickinson, ICN and Hitachi Chemical Diagnostics.

Doris-Ann also works closely with other global IVD industry associations and in the UK as part of Life Sciences UK. She was awarded an MBE in January 2011 and was recognised as a Friend of the Royal College of Pathologists in November 2012 and also as Friend of the Association for Clinical Biochemistry in July 2015. She is currently a Vice-President of the Parliamentary & Scientific Committee. She is also an active member of a number of Government and NHS steering groups & boards.

During 2016, Doris-Ann was invited to attend the High-Level meeting on Antimicrobial Resistance at the United Nations General Assembly in New York (September) and was a member of the Precision Medicine delegation to India for the Prime Minister’s visit in November.
NovarumTM Dx Founder and BBI Group Head of Mobile. With a PhD in Chemistry and around 15 years working in the diagnostics arena, Dr Neil Polwart specialises in leading mHealth development, delivering connected health and true point of care technology solutions. Neil Polwart has worked in the field of biosensors, for nearly 20 years, developing and commercialising in-field tests for medical and environmental applications. His technical experience includes physics, chemistry, biotechnology and software, but in recent years, Neil has been increasingly focused on commercialisation. In 2012, Neil led a joint venture - namely, Novarum DX based in Edinburgh, combining BBI’s diagnostics expertise with image-capture software which transforms a smartphone into a mobile diagnostic reader.

In late 2016, BBI Group completed the acquisition of Novarum DX, following successful commercialisation of the technology with a number of key clients. Neil now heads up mobile within BBI Group, driving the ambitions of this global diagnostics business into the mHealth arena.
Alison Dennis is co-head of the life sciences sector group and a noted expert in EU regulatory and compliance matters for medical device and IVD companies.
Michael Wakeman is a pharmacist and healthcare consultant. He has a master’s degree in pharmaceutical analysis as well as nutritional medicine, and clinical oncology. He is currently completing a PhD.

He has extensive experience in natural medicines research and worked alongside Nobel laureate in medicine, Sir James Black-whilst MD at Scotia Pharmaceuticals. Since then he has worked as a consultant to a number of blue chip organisations including Genzyme, the US biotech giant, and a number of UK based, multinational companies in the research and development of their business.


Guy Checketts photo


Julie Hart photo

Guy Checketts is the Head of Transformation and Evaluation within the SIP Programme at the Oxford AHSN; Guy has had an extensive career throughout the medical device industry and has developed, launched and managed many new medical devices across multiple segments in the UK, Europe and the US.
Julie Hart is Director of Strategic and Industry Partnerships at the Oxford Academic Health Science Network (AHSN) who trained as a research microbiologist and has been leading commercial teams in the diagnostics and life sciences businesses for over 25 years.

The Strand Hotel, London



"Just minutes from Covent Garden and the Thames, our central London hotel has been welcoming guests since 1909. Beneath today’s contemporary décor you’ll find fascinating stories and some original Art Deco touches."

Visit the Strand Hotel's website


International Airports

Heathrow – 47 mins
Gatwick – 1hr 4 mins
London City – 26 mins

Nearest Tube

Covent Garden – 5 mins walk
Leicester Square Station – 8 mins walk
Embankment Station - 8 mins walk

Mainline Rail Stations

Charing Cross – 6 mins walk

Who Will Attend?

Over 200 Delegates will be on hand for the 2nd annual summit, these include-

  • Senior Clinical Scientist-King's College Hospital
  • Laboratory Manager-Hull and East Yorkshire hospitals trust
  • Laboratory Manager-Aneurin Bevan University Health Board
  • Director of Operations-The Leeds Teaching Hospitals NHS Trust
  • Biomedical Scientist-University Hospital Southampton NHS Foundation Trust
  • Consultant Microbiologist-North Middlesex Hospital London
  • Clinical Scientist-East Kent Hospitals University NHS Foundation Trust/li>
  • Screening Laboratory and POCT Manager-Oxford University Hospitals NHS Foundation Trust




  • Exhibition Space 3x2 Metre: Table, Chair, Table Cloth (Next to Refreshments)
  • Speaking slot on plenary x 20 mins morning slot
  • Workshop x 30 mins
  • 4 Tickets to attend
  • Delegate bag inserts x 200
  • Event guide advert full page colour
  • Lanyard Branding colour
  • Delegate bag Branding two tone colour
  • Delegate bag insert x 200 A4/A5
  • Branding on Website mast head as main sponsor
  • Profile in Event Guide
  • Delegate list

  • Branding and logo design on Lanyards
  • 2 tickets to attend
  • Profile and branding in event guide
  • Profile and branding on event website

  • 250-word advertorial in monthly newsletter pre-Summit
  • 1 ticket to attend

  • Pre-arranged one-on-one meetings ensure that you have personal time with your choice of delegates.

  • Full delegate profiles are provided prior to the conference to ensure that onsite, you meet with relevant delegates who are truly interested in your products and services.

  • Private Surgery space

  • Exhibition Space 3x2 Metre: Table, Chair, Table Cloth
  • Speaking slot on plenary x 15 mins
  • Workshop x 30 mins
  • 2 Tickets to attend
  • Branding on Website
  • Profile in Event Guide
  • Delegate list

  • Exhibition Space 3x2 Metre: Table, Chair, Table Cloth
  • 2 Tickets to attend
  • Branding on Website
  • Profile in Event Guide
  • Delegate list

  • Branding and logo design on Cloth Bags
  • 2 tickets to attend
  • Profile and branding in event guide
  • Profile and branding on event website

  • 30-minute workshop
  • 2 tickets to attend
  • Branding on Website
  • Profile in Event guide
  • Delegate list

If you're interested in discussing the packages that we have on offer get in touch by emailing: Scott@4allofus.org.uk

To view the benefits of sponsorship packages download our media pack by clicking here:

The UK Diagnostics Summit is brought to you by 4 All of us, a mission-driven organisation working to tackle the impact of Antimicrobial Resistance by investing and supporting those working at the forefront of AMR. 4 All of us currently works with Public Health England on the Antibiotic Guardian Campaign as well as supporting the UK AMR Diagnostics Collaborative. We are proud to have the support of the British In-Vitro Diagnostics Association for the UK Summit.

Contact Us

Name *